[8] Use of heterologus expression systems to study autoimmune drug-induced hepatitis
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 272, 76-85
- https://doi.org/10.1016/s0076-6879(96)72010-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Human cytochromes P450 expressed in Escherichia coli: production of specific antibodiesToxicology, 1996
- Specificity of in vitro Covalent Binding of Tienilic Acid Metabolites to Human Liver Microsomes in Relationship to the Type of Hepatotoxicity: Comparison with Two Directly Hepatotoxic DrugsChemical Research in Toxicology, 1994
- Autoantibodies against Cytochromes P450: Role in Human DiseasesPublished by Elsevier ,1994
- Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5Gene, 1993
- Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymesEuropean Journal of Biochemistry, 1993
- Drug-Induced Allergic HepatitisSeminars in Liver Disease, 1990
- Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.Journal of Clinical Investigation, 1990
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- Nucleotide sequence of bacteriophage λ DNAJournal of Molecular Biology, 1982
- A rapid and sensitive method for determination of covalent binding of benzo[a]pyrene to proteinsChemico-Biological Interactions, 1981